Suchitra Kamle

1.1k total citations
27 papers, 542 citations indexed

About

Suchitra Kamle is a scholar working on Molecular Biology, Plant Science and Oncology. According to data from OpenAlex, Suchitra Kamle has authored 27 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 8 papers in Plant Science and 7 papers in Oncology. Recurrent topics in Suchitra Kamle's work include Studies on Chitinases and Chitosanases (12 papers), Genetically Modified Organisms Research (7 papers) and Peptidase Inhibition and Analysis (6 papers). Suchitra Kamle is often cited by papers focused on Studies on Chitinases and Chitosanases (12 papers), Genetically Modified Organisms Research (7 papers) and Peptidase Inhibition and Analysis (6 papers). Suchitra Kamle collaborates with scholars based in United States, India and China. Suchitra Kamle's co-authors include Sher Ali, Jack A. Elias, Chun Geun Lee, Bing Ma, Chang-Min Lee, Chuan He, Bedia Akosman, Raj K. Bhatnagar, Abhishek Ojha and Arvind Kumar and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Immunity.

In The Last Decade

Suchitra Kamle

25 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suchitra Kamle United States 15 372 157 94 90 58 27 542
Bianca Alves Pauletti Brazil 16 363 1.0× 39 0.2× 80 0.9× 59 0.7× 65 1.1× 35 567
Jinzhi Duan China 9 361 1.0× 75 0.5× 41 0.4× 100 1.1× 22 0.4× 13 532
Lior Nissim Israel 9 628 1.7× 50 0.3× 57 0.6× 92 1.0× 56 1.0× 14 723
Wenjuan Wu China 12 480 1.3× 90 0.6× 69 0.7× 157 1.7× 26 0.4× 21 743
Yaqi Zhao China 14 302 0.8× 94 0.6× 87 0.9× 190 2.1× 22 0.4× 34 646
Mahmut Parlak United States 12 633 1.7× 104 0.7× 74 0.8× 152 1.7× 16 0.3× 12 797
Shaliny Ramachandran Canada 12 665 1.8× 139 0.9× 143 1.5× 137 1.5× 23 0.4× 14 864
Xiaoqing Han China 16 308 0.8× 244 1.6× 21 0.2× 234 2.6× 33 0.6× 28 681
Mollie S. Schubert United States 6 559 1.5× 50 0.3× 58 0.6× 55 0.6× 49 0.8× 6 626
Xiaomeng An China 11 323 0.9× 84 0.5× 30 0.3× 60 0.7× 14 0.2× 20 460

Countries citing papers authored by Suchitra Kamle

Since Specialization
Citations

This map shows the geographic impact of Suchitra Kamle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suchitra Kamle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suchitra Kamle more than expected).

Fields of papers citing papers by Suchitra Kamle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suchitra Kamle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suchitra Kamle. The network helps show where Suchitra Kamle may publish in the future.

Co-authorship network of co-authors of Suchitra Kamle

This figure shows the co-authorship network connecting the top 25 collaborators of Suchitra Kamle. A scholar is included among the top collaborators of Suchitra Kamle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suchitra Kamle. Suchitra Kamle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Bing, Suchitra Kamle, Chang-Min Lee, et al.. (2024). Chitinase 3–like-1 Inhibits Innate Antitumor and Tissue Remodeling Immune Responses by Regulating CD47-SIRPα– and CD24-Siglec10–Mediated Phagocytosis. The Journal of Immunology. 213(9). 1279–1291. 1 indexed citations
2.
Kamle, Suchitra, Bing Ma, Hina Khan, et al.. (2024). Chitinase 3-like-1 (CHI3L1) in the pathogenesis of epidermal growth factor receptor mutant non-small cell lung cancer. Translational Oncology. 49. 102108–102108.
3.
Taifour, Tarek, Sherif Samer Attalla, Dongmei Zuo, et al.. (2023). The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer. Immunity. 56(12). 2755–2772.e8. 70 indexed citations
4.
Akosman, Bedia, Jia‐Shu Chen, Suchitra Kamle, et al.. (2023). Chi3l1 Is a Modulator of Glioma Stem Cell States and a Therapeutic Target in Glioblastoma. Cancer Research. 83(12). 1984–1999. 29 indexed citations
5.
Kamle, Suchitra, Bing Ma, Chang Min Lee, et al.. (2022). Host chitinase 3-like-1 is a universal therapeutic target for SARS-CoV-2 viral variants in COVID-19. eLife. 11. 6 indexed citations
6.
Lee, Jae‐Hyun, Chang-Min Lee, Mun-Ock Kim, et al.. (2022). Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 67(3). 309–319. 10 indexed citations
7.
Lee, Suh‐Young, Chang-Min Lee, Bing Ma, et al.. (2022). Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis. Frontiers in Pharmacology. 13. 826471–826471. 15 indexed citations
8.
Ma, Bing, Suchitra Kamle, Bedia Akosman, et al.. (2022). CHI3L1 enhances melanoma lung metastasis via regulation of T cell co-stimulators and CTLA-4/B7 axis. Frontiers in Immunology. 13. 1056397–1056397. 18 indexed citations
9.
Kamle, Suchitra, Bing Ma, Chuan He, et al.. (2021). Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19. JCI Insight. 6(21). 24 indexed citations
10.
Zhang, Songhua, Bing Ma, Chang Min Lee, et al.. (2021). Role of Chitinase 3-Like 1 Protein in the Pathogenesis of Hepatic Insulin Resistance in Nonalcoholic Fatty Liver Disease. Cells. 10(2). 201–201. 16 indexed citations
11.
Ma, Bing, Bedia Akosman, Suchitra Kamle, et al.. (2021). CHI3L1 regulates PD-L1 and anti–CHI3L1–PD-1 antibody elicits synergistic antitumor responses. Journal of Clinical Investigation. 131(21). 41 indexed citations
12.
He, Chuan, Chun Geun Lee, Bing Ma, et al.. (2020). N -Glycosylation Regulates Chitinase 3–like-1 and IL-13 Ligand Binding to IL-13 Receptor α2. American Journal of Respiratory Cell and Molecular Biology. 63(3). 386–395. 22 indexed citations
14.
Zhou, Yang, Chuan He, Daniel S. Yang, et al.. (2018). Galectin-3 Interacts with the CHI3L1 Axis and Contributes to Hermansky–Pudlak Syndrome Lung Disease. The Journal of Immunology. 200(6). 2140–2153. 42 indexed citations
15.
Kamle, Suchitra, Dawei Li, Abhishek Ojha, & Arvind Kumar. (2018). Development of an Enzyme-Linked Immunosorbent Assay for the Detection of GM Proteins in Transgenic Crops/Produce. Methods in molecular biology. 1902. 159–166. 3 indexed citations
16.
Li, Zheqi, Zhenghua Wu, Hao Chen, et al.. (2015). Induction of anterior gradient 2 (AGR2) plays a key role in insulin-like growth factor-1 (IGF-1)-induced breast cancer cell proliferation and migration. Medical Oncology. 32(6). 577–577. 22 indexed citations
17.
Li, Dawei, Dongsheng Li, Hema Negi, et al.. (2015). A human leucyl-tRNA synthetase as an anticancer target. OncoTargets and Therapy. 8. 2933–2933. 11 indexed citations
18.
Kamle, Suchitra. (2013). Reverberations on Biosafety Issues Pertaining to Genetically Modified Crops. 2(2). 3 indexed citations
19.
Kamle, Suchitra, Abhishek Ojha, & Arvind Kumar. (2012). Development of Enzyme-Linked Immunosorbent Assay for the Detection of Bt Protein in Transgenic Cotton. Methods in molecular biology. 958. 131–138. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026